Lisanti Capital Growth, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$3,945,000
+5.8%
81,398
-7.8%
0.80%
-34.7%
Q1 2020$3,729,000
-28.9%
88,266
-28.0%
1.23%
-11.5%
Q4 2019$5,243,000
+35.5%
122,551
+14.0%
1.39%
+10.2%
Q3 2019$3,870,000
+245.8%
107,525
+156.9%
1.26%
+246.7%
Q2 2019$1,119,000
-60.9%
41,860
-60.7%
0.36%
-64.1%
Q1 2019$2,860,000
+613.2%
106,535
+762.3%
1.01%
+67.4%
Q2 2016$401,000
-61.8%
12,355
-67.1%
0.60%
-51.4%
Q1 2016$1,050,000
+105.9%
37,570
+162.9%
1.24%
+132.1%
Q4 2015$510,000
-19.6%
14,293
-25.5%
0.54%
-6.1%
Q3 2015$634,000
-66.0%
19,185
-56.9%
0.57%
-57.5%
Q2 2015$1,863,000
-6.5%
44,476
-27.2%
1.34%
+18.3%
Q1 2015$1,992,000
-51.7%
61,118
-52.9%
1.14%
-44.9%
Q4 2014$4,121,000
+60.7%
129,791
+25.3%
2.06%
+59.9%
Q3 2014$2,564,000
+164.6%
103,550
+167.2%
1.29%
+216.7%
Q4 2013$969,000
-46.8%
38,760
-41.6%
0.41%
-51.0%
Q3 2013$1,823,00066,3550.83%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders